Alteogen Signs a Non-exclusive Licensing Deal With Global Pharmaceutical Company for Use of Hybrozyme Technology
Alteogen Inc. has revealed that it has entered into a non-exclusive agreement with leading 10 Global Pharmaceutical Company to use its new technology called Hybrozyme, …